Tobetsa mona ho bonts'a lifolakha tsa HAO leqepheng lena mme u lefelle katleho feela

Litaba tsa mohala

FDA e hlakola kalafo ea maqeba a ho buuoa ho bakuli ba nang le prediabetes, lefu la tsoekere le botenya

ngotsoeng ke mohlophisi

Ilya Pharma AB (Khampani), k'hamphani ea kliniki ea immunotherapy kajeno e phatlalalitse hore FDA e hlakotse IND bakeng sa mokhethoa oa eona ea ka sehloohong ILP100-Topical le hore Khampani e potlakisa litokisetso tsa boithuto bo boholo ba Mokhahlelo oa 2, bo hlophisitsoeng joalo ka teko ea bohlokoa. ILP100-Topical ke mofuta oa pele oa immunotherapy o etselitsoeng ho alafa maqeba a ho buuoa ho bakuli ba nang le prediabetes, lefu la tsoekere le botenya. Bakuli bana ba lieha ho fola ka libeke ho isa ho likhoeli ka mor'a ho buuoa le kotsi e ntseng e eketseha ea mathata a tebileng a maqeba.

Robert D. Galiano, MD, Moprofesa oa Motlatsi oa FACS; Motsamaisi oa Lipatlisiso; Division of Plastic Surgery University of Northwestern University Feinberg School of Medicine, e tla ba Mofuputsi oa Naha oa Coordinating and Study Chair bakeng sa thuto e tla kenyelletsa bakuli ba 260. Kamora mosebetsi o ntseng o tsoela pele ke Morero oa Litsebi tsa Maqeba/FDA Clinical Endpoints Project (WEF-CEP) le litloaelo libakeng tse ling tse joalo ka oncology le ramatiki ea ramatiki, ntlha ea mantlha e khethiloeng ke pheletso e kopaneng ea pholiso ea mahala. Phuputso e na le moralo o ikamahanyang le maemo 'me e na le likarolo tse peli - ea pele ke karolo ea ho fumana lethal dose 'me ea bobeli ke karolo ea netefatso. Ka lebaka la moralo oa taolo ea ka hare, moo mokuli e mong le e mong a nang le taolo ea hae ka leqeba le le leng le phekoloang ka placebo le leqeba le le leng le phekoloang ka ILP100-Topical, thuto e fokotsehile haholo, palo ea bakuli ba ngolisitsoeng e fokotsehile le leeme pakeng tsa lihlopha tsa phekolo. fokotsitsoe.

Ngaka Galiano o ile a hlalosa: “Ha ho hlokahale hore motho a be le lefu la tsoekere hore a be le mathata a ho fola ha maqeba, ’me sena ha se ananeloe feela, empa hape ha re na liphekolo tse lebisitseng ho holofala hona ha ho fola. Phello ea botenya ke seoa se khutsitseng 'me se ama mokhoa o mong le o mong oa ho buuoa. Kalafo e ntlafatsang pholiso ea maqeba a ho buuoa e ne e tla fella ka liphello tse ntlafetseng litsebong tsohle le mekhoa ea ho buuoa, eseng feela ho fokotsa matsoele. Kahoo ke thabetse ho etella pele nyeoe ena kaha ke bone liphetho tse khahlang tse seng li fumanoe ke Ilya thutong ea bona ea Mokhahlelo oa Pele. ”

Mookameli oa Ilya Pharma le Mothehi-'moho le eena Evelina Vågesjö oa phaella: "Tlhaloso e tlile kapele ho feta kamoo ho neng ho lebelletsoe, joale re ikemiselitse ho phekola mokuli oa pele Q3 selemong sena. Hona hape ke motsotso oa bohlokoa ho Ilya Pharma kamora boiteko bo makatsang ba sehlopha sa rona se seholo. Ka ho sebetsa 'moho le Ngaka Galiano le sehlopha sa litsebi le li-KOL, re lumela hore re thehile moralo o nepahetseng oa teko o tla bonts'a melemo ea phetoho ea ILP100-Topical ho bakuli, ho qala ka batho bana ba kotsing. Ho feta moo, ketsahalo ena ea bohlokoa e tiisa sethala sa rona sa thekenoloji ea ILP le batho ba bang ba nts'etsopele ea lithethefatsi tseo re hlokometseng hore ba ntse ba eketseha. 

Litaba Tse Amanang

Mabapi le mongoli

mohlophisi

Mohlophisi e moholo oa eTurboNew ke Linda Hohnholz. O lula ntlong e kholo ea eTN e Honolulu, Hawaii.

Leave a Comment

Arolelana ho...